TRNS vs CMPR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TRNS · Transcat$92.97 ▼ 4.68%
CMPR · Cimpress$53.81 ▼ 0.79%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TRNS +73.7%
- CMPR -22.2%
Head to head
| Metric | TRNS | CMPR |
|---|---|---|
| Price | $92.97 | $53.81 |
| Change today | ▼ 4.68% | ▼ 0.79% |
| Market cap | $874.37M | $1.32B |
| Return, 3 months | +6.4% | -38.5% |
| Return, year to date | +63.9% | -19.2% |
| Return, 1 year | +71.4% | -20.5% |
| P/E (TTM) | 189.7 | 15.9 |
| P/B | 2.8 | -2.7 |
| P/E percentile vs own 5y | 95th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +18.0% | +8.2% |
| Net profit growth (YoY) | +90.1% | -115.2% |
| Gross margin | 32.8% | 45.6% |
| Operating margin | 3.6% | 6.3% |
| Net margin | 1.3% | 2.2% |
| Return on equity | 1.5% | – |
| Analyst target vs. price | +19.2% | +78.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 46 | 31 |
| 30-day volatility | 76.7% | 83.0% |
| Max drawdown, 1 year | -18.6% | -48.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CMPR is the largest of the group by market value.
- TRNS has returned the most over the past year.
- CMPR carries the lowest trailing P/E.
- TRNS is growing revenue fastest.
- CMPR keeps the most profit per dollar of sales.
- TRNS has been the calmest stock over the last 30 days.